Source:http://linkedlifedata.com/resource/pubmed/id/20731356
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
2010-9-15
|
pubmed:abstractText |
Abnormal proliferation of vascular smooth muscle cells (VSMCs) plays a central role in the pathogenesis of atherosclerosis. ?-Sitosterol, an important phytosterol found in plant food, is known to exert antiatherosclerosis activity. However, the molecular mechanisms underlying ?-sitosterol-induced antiproliferation of VSMCs were still not clear. This study demonstrated that ?-sitosterol (1-20 ?M) concentration-dependently inhibited proliferation of rat aortic smooth muscle cells (RASMCs) without cytotoxic effect. Flow cytometric analysis revealed that ?-sitosterol arrested cell cycle progression through down-regulation of cyclin E and cyclin-dependent kinase (CDK)2 and up-regulation of p21cip1. In the ?-sitosterol-treated RASMCs, the formation of the CDK2-p21cip1 complex was increased and the assayable CDK2 activity was decreased. Knockdown of the expression of p21cip1 gene prevented ?-sitosterol-induced cell cycle arrest in RASMCs. In conclusion, ?-sitosterol inhibited VSMC proliferation by increasing the levels of p21cip1 protein, which in turn inhibited the CDK2 activity, and finally interrupted the progress of the cell cycle.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1a protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Sitosterols,
http://linkedlifedata.com/resource/pubmed/chemical/sitosterol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1520-5118
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10064-9
|
pubmed:meshHeading |
pubmed-meshheading:20731356-Animals,
pubmed-meshheading:20731356-Aorta, Thoracic,
pubmed-meshheading:20731356-Atherosclerosis,
pubmed-meshheading:20731356-Cell Cycle,
pubmed-meshheading:20731356-Cell Proliferation,
pubmed-meshheading:20731356-Cells, Cultured,
pubmed-meshheading:20731356-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:20731356-Hypolipidemic Agents,
pubmed-meshheading:20731356-Male,
pubmed-meshheading:20731356-Muscle, Smooth, Vascular,
pubmed-meshheading:20731356-Rats,
pubmed-meshheading:20731356-Rats, Sprague-Dawley,
pubmed-meshheading:20731356-Sitosterols,
pubmed-meshheading:20731356-Up-Regulation
|
pubmed:year |
2010
|
pubmed:articleTitle |
?-Sitosterol inhibits cell cycle progression of rat aortic smooth muscle cells through increases of p21cip1 protein.
|
pubmed:affiliation |
Taipei Medical University-Wang-Fang Hospital, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|